Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL) [clinicaltrials:NCT00301561]

Bio2RDF uri

Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL) [clinicaltrials:NCT00301561]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00301561

Bio2RDF identifier

NCT00301561

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00301561

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00301561

actual enrollment [clinicaltrials_vocabulary:actual-enrollment]

459

http://www.w3.org/2001/XMLSchema#integer

arm group [clinicaltrials_vocabulary:arm-group]

NCT00301561 arm group c4ca4238a0b923820dcc509a6f75849b [clinicaltrials_resource:NCT00301561/arm-group/c4ca4238a0b923820dcc509a6f75849b]

NCT00301561 arm group c81e728d9d4c2f636f067f89cc14862c [clinicaltrials_resource:NCT00301561/arm-group/c81e728d9d4c2f636f067f89cc14862c]

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:bfb0376ab97bb022554cdf06f8723476

brief summary [clinicaltrials_vocabulary:brief-summary]

Access to antiretrovira ...... t the gold standard approach.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL)

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Increase in the CD4 cell count measured with a FACSCount apparatus after 24 months of antiretroviral therapy 24 months [clinicaltrials_resource:e7aa1d44278462a0c1655f626670f33e]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Increase in the CD4 cell count measured with a FACSCount apparatus after 24 months of antiretroviral therapy 24 months [clinicaltrials_resource:0deeb5a07d2178c604cb0db6d0dec70c]

Increase in the CD4 cell count measured with a FACSCount apparatus after 24 months of antiretroviral therapy 24 months [clinicaltrials_resource:24e3c1044e88758981e5e1a5a7461e1b]

Increase in the CD4 cell count measured with a FACSCount apparatus after 24 months of antiretroviral therapy 24 months [clinicaltrials_resource:4a8305bb09ddb3ad6c19efd36f0a1757]

Increase in the CD4 cell count measured with a FACSCount apparatus after 24 months of antiretroviral therapy 24 months [clinicaltrials_resource:4bdf13b79ed45023c8e4cb028458be2b]

Increase in the CD4 cell count measured with a FACSCount apparatus after 24 months of antiretroviral therapy 24 months [clinicaltrials_resource:69ba8afa81282c28a5f14232df2bdc02]

Increase in the CD4 cell count measured with a FACSCount apparatus after 24 months of antiretroviral therapy 24 months [clinicaltrials_resource:6f5400fadee6a1c56528c3c356a6fa1e]

Increase in the CD4 cell count measured with a FACSCount apparatus after 24 months of antiretroviral therapy 24 months [clinicaltrials_resource:76ead0bd3fef02afd7625968f071ba41]

Increase in the CD4 cell count measured with a FACSCount apparatus after 24 months of antiretroviral therapy 24 months [clinicaltrials_resource:ab2b070e8de2ec3413bd01cdb05c61f3]

Increase in the CD4 cell count measured with a FACSCount apparatus after 24 months of antiretroviral therapy 24 months [clinicaltrials_resource:b39ac7c2e0da5f56d4a1ba182e862ccb]

Increase in the CD4 cell count measured with a FACSCount apparatus after 24 months of antiretroviral therapy 24 months [clinicaltrials_resource:bbad5f29a2d085ab4a5badcf9c51286a]

completion date [clinicaltrials_vocabulary:completion-date]

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

condition [clinicaltrials_vocabulary:condition]

HIV Infections [clinicaltrials_resource:3f980d9baec1b9b18d5a0f38f4921607]

AIDS [clinicaltrials_resource:b1c735ffa03683c4bfbedb3b43d4f647]

country [clinicaltrials_vocabulary:country]

Cameroon [clinicaltrials_resource:4be25f9d27da71d4e98775668b5b12af]

detailed description [clinicaltrials_vocabulary:detailed-description]

Justification Ac ...... sing access to ART in Africa.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00301561 [clinicaltrials_resource:9dd7fd993eaaa0ef98bf22b7113263fe]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2006-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

keyword [clinicaltrials_vocabulary:keyword]

Africa

http://www.w3.org/2001/XMLSchema#string

Antiretroviral treatment

http://www.w3.org/2001/XMLSchema#string

Expanded access

http://www.w3.org/2001/XMLSchema#string

Treatment Naive

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2011-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

French National Agency for Research on AIDS and Viral Hepatitis [clinicaltrials_resource:70aef9de6f48dc8b934933b4434a772f]

location [clinicaltrials_vocabulary:location]

Hôpital de district d'Ayos [clinicaltrials_resource:dbd10a58025307e57531668d0bb11163]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00301561

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

Expanded Access to Antiretrovi ...... Approach (ANRS 12110 STRATALL)

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

ANRS 12110 STRATALL

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Christian Laurent [clinicaltrials_resource:ac3aec96c648c280bd36e69dac917084]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

Cameroon: Ministry of Public Health [clinicaltrials_resource:d5e822b98467d7d1fc100626207497d5]

phase [clinicaltrials_vocabulary:phase]

Phase 3 [clinicaltrials_resource:8357418e2694434468870b487644532d]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

source [clinicaltrials_vocabulary:source]

French National Agency for Research on AIDS and Viral Hepatitis [clinicaltrials_resource:70aef9de6f48dc8b934933b4434a772f]

start date [clinicaltrials_vocabulary:start-date]

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00301561 study design [clinicaltrials_resource:31b902e50db8be569011bf37da670d1a]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00301561

verification date [clinicaltrials_vocabulary:verification-date]

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00301561

http://www.w3.org/2001/XMLSchema#string

title

Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL)

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Antiretroviral Treatment Simpl ...... ) [clinicaltrials:NCT00301561]

@en